This article was originally published in The Tan Sheet
A smart card-enabled Cholesterol Monitor will be available to consumers by year-end pending FDA approval, the Post Falls, Idaho-based company says. The device uses one drop of blood to determine cholesterol levels in three minutes; the results are then encrypted and downloaded on the included Privalink Microsoft Smart Card for Windows, allowing them to be sent to doctors or pharmacists via the Internet; the data also can be delivered in person. Other software records cholesterol levels for later review. Print advertising and an infomercial will promote the product to consumers and professionals, who must cooperate in establishing an information system to receive and store the data. The monitor will retail for $129.95, with packets of six test kits selling for $19.95
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC